Prolonged use of oral contraceptive pill, a co-factor for the development of cervical cancer

This study was carried out to assess the use of oral contraceptive pill as a co-factor for the development of cervical cancer. Among the 100 participants, 71% used oral contraceptives pill. Maximum (40%) used oral contraceptive pill for >5 years whereas 31% for <5 years. Histopathologically diagnosed invasive squamous cell carcinoma was 84% and adenocarcinoma was 16%

Prolonged use of oral contraceptive pill, a co-factor for the development of cervical cancer

This study was carried out to assess the use of oral contraceptive pill as a co-factor for the development of cervical cancer. Among the 100 participants, 71% used oral contraceptives pill. Maximum (40%) used oral contraceptive pill for >5 years whereas 31% for <5 years. Histopathologically diagnosed invasive squamous cell carcinoma was 84% and adenocarcinoma was 16%

A 17 year old girl with gradual swelling of lower abdomen

This article has no abstract. The first 100 words appear below: A 17 year old girl presented at the outpatient department with the history of gradual swelling of lower abdomen, early onset of menstruation (precocious puberty) at the age of 7 years followed by secondary amenorrhea for 10 years, growth retardation and breast atrophy. She also complained that her secondary sexual characteristic did not develop. She had no family history of growth retardation or precocious puberty. Her breast showed infantile growth. She had no history of fever, abdominal pain, alteration of bowel habit, weight loss, or loss of appetite. On examination, she was afebrile and vitally stable

A 17 year old girl with gradual swelling of lower abdomen

This article has no abstract. The first 100 words appear below: A 17 year old girl presented at the outpatient department with the history of gradual swelling of lower abdomen, early onset of menstruation (precocious puberty) at the age of 7 years followed by secondary amenorrhea for 10 years, growth retardation and breast atrophy. She also complained that her secondary sexual characteristic did not develop. She had no family history of growth retardation or precocious puberty. Her breast showed infantile growth. She had no history of fever, abdominal pain, alteration of bowel habit, weight loss, or loss of appetite. On examination, she was afebrile and vitally stable

Iron Overload and Breast Cancer: Iron Chelation as a Potential Therapeutic Approach

Breast cancer has historically been one of the leading causes of death for women worldwide. As of 2020, breast cancer was reported to have overtaken lung cancer as the most common type of cancer globally, representing an estimated 11.3% of all cancer diagnoses. A multidisciplinary approach is taken for the diagnosis and treatment of breast cancer that includes conventional and targeted treatments. However, current therapeutic approaches to treating breast cancer have limitations, necessitating the search for new treatment options. Cancer cells require adequate iron for their continuous and rapid proliferation. Excess iron saturates the iron-binding capacity of transferrin, resulting in non-transferrin-bound iron (NTBI) that can catalyze free-radical reactions and may lead to oxidant-mediated breast carcinogenesis. Moreover, excess iron and the disruption of iron metabolism by local estrogen in the breast leads to the generation of reactive oxygen species (ROS). Therefore, iron concentration reduction using an iron chelator can be a novel therapeutic strategy for countering breast cancer development and progression. This review focuses on the use of iron chelators to deplete iron levels in tumor cells, specifically in the breast, thereby preventing the generation of free radicals. The inhibition of DNA synthesis and promotion of cancer cell apoptosis are the targets of breast cancer treatment, which can be achieved by restricting the iron environment in the body. We hypothesize that the usage of iron chelators has the therapeutic potential to control intracellular iron levels and inhibit the breast tumor growth. In clinical settings, iron chelators can be used to reduce cancer cell growth and thus reduce the morbidity and mortality in breast cancer patients

Use of Intraoperative Transesophageal Echocardiography to Predict Atrial Fibrillation after Coronary Artery Bypass Grafting

Background Postoperative atrial fibrillation in coronary artery bypass graft surgery occurs in 10-40% of patients. It is associated with a significant degree of morbidity and results in prolonged lengths of stay in both the intensive care unit and hospital. Methods The authors prospectively evaluated patients undergoing coronary artery bypass with detailed transesophageal echocardiography examinations conducted before and after cardiopulmonary bypass to study whether risk factors for atrial fibrillation could be identified. Demographic and surgical parameters were also included in the analysis. Selected variables were subjected to univariate and subsequent multivariate analyses to test for their independent or joint influence on atrial fibrillation. Results Seventy-nine patients had assessable transesophageal echocardiography examinations. Significant univariate predictors of atrial fibrillation included advanced age (P = 0.002), pre-cardiopulmonary bypass left atrial appendage area (P = 0.04), and post-cardiopulmonary bypass left upper pulmonary vein systole/diastole velocity ratio (P = 0.03). When these three factors were considered together in a multiple logistic regression analysis, left upper pulmonary vein systole/diastole velocity ratio was a significant predictor (P < 0.05), as was the joint effect of age plus pre-cardiopulmonary bypass left atrial appendage area (P = 0.005). The probability of developing atrial fibrillation for the combination of age = 75 yr, post-cardiopulmonary bypass left upper pulmonary vein systole/diastole velocity ratio = 0.5, and left atrial appendage area = 4.0 cm was 0.83 (95% confidence interval, 0.51-0.96). Conclusions Early identification of patients at risk for postoperative atrial fibrillation may be feasible using the parameters identified in this study